InDex Pharmaceuticals Holding AB
STO:FLERIE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
SE |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
G
|
Gansu Qilianshan Cement Group Co Ltd
SSE:600720
|
CN |
|
M
|
Mayr Melnhof Karton AG
VSE:MMK
|
AT |
|
Leo Group Co Ltd
SZSE:002131
|
CN |
|
Zuari Agro Chemicals Ltd
NSE:ZUARI
|
IN |
|
Crescent Capital BDC Inc
NASDAQ:CCAP
|
US |
|
Axonics Inc
NASDAQ:AXNX
|
US |
|
M
|
Mast Energy Developments PLC
LSE:MAST
|
UK |
|
Founder's Consultants Holdings Inc
TSE:6542
|
JP |
|
A
|
Amasse Capital Holdings Ltd
HKEX:8168
|
HK |
Bankruptcy Probability
InDex Pharmaceuticals Holding AB's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
InDex Pharmaceuticals Holding AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
2.3B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
InDex Pharmaceuticals Holding AB's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, InDex Pharmaceuticals Holding AB has total debt of 1.6m SEK. This includes both short-term (0 SEK) and long-term (1.6m SEK) debt.
You can find a full breakdown on its Balance Sheet.
